(Q33638362)

28 July 2017

1 reference

title

Tumor suppressor genes and breast cancer (English)

1 reference

28 July 2017

Buchholz TA

1

1 reference

28 July 2017

Weil MM

2

1 reference

28 July 2017

Story MD

3

1 reference

28 July 2017

Strom EA

4

1 reference

28 July 2017

Brock WA

5

1 reference

28 July 2017

McNeese MD

6

1 reference

28 July 2017

publication date

1 January 1999

1 reference

Radiation Oncology Investigations

28 July 2017

published in

1 reference

28 July 2017

volume

7

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

55-65

1 reference

Cancer-susceptibility genes. Gatekeepers and caretakers

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Hereditary cancer: two hits revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

The genetics of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

The p53-deficient mouse: a model for basic and applied cancer studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Loss of p53 protein during radiation transformation of primary human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Gain of function mutations in p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

p53 function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Radiation-induced cell cycle arrest compromised by p21 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

P53 Expression and the Result of Adjuvant Therapy of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Linkage of early-onset familial breast cancer to chromosome 17q21

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Changes in BRCA2 expression during progression of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

BRCA1 required for transcription-coupled repair of oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Association of BRCA1 with Rad51 in mitotic and meiotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

BRCA1 mutations in primary breast and ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Breast and other cancers in families with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Heterozygous ATM mutations do not contribute to early onset of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Radiosensitivity in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Interaction between ATM protein and c-Abl in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

Functional interaction between DNA-PK and c-Abl in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

DNA-dependent protein kinase acts upstream of p53 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A2%3C55%3A%3AAID-ROI1%3E3.0.CO%3B2-%23

10.1002/(SICI)1520-6823(1999)7:2<55::AID-ROI1>3.0.CO;2-#

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference